PTGS2 and neoplasm: For example, inhibiting the COX2/prostaglandin pathway reduced PD-L1 expression in tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells in mice with MBT2 bladder carcinomas33 and induced TAMs to adopt an inflammatory M1 phenotype in mice with APCMin intestinal tumors.34